Works matching IS 17427835 AND DT 2021 AND VI 129 AND IP 3
Results: 14
Effect of Roux‐en‐Y gastric bypass on the pharmacokinetic‐pharmacodynamic relationships of liquid and controlled‐release formulations of oxycodone.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 232, doi. 10.1111/bcpt.13634
- By:
- Publication type:
- Article
Effects of dipyrone and acetylsalicylic acid on contractions of distal cauda epididymis duct, serum testosterone and sperm count in rats.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 183, doi. 10.1111/bcpt.13633
- By:
- Publication type:
- Article
Acute liver failure requiring transplantation: A possible link to ulipristal acetate treatment?
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 278, doi. 10.1111/bcpt.13631
- By:
- Publication type:
- Article
CORRIGENDUM.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 283, doi. 10.1111/bcpt.13630
- Publication type:
- Article
The effect of first‐line antituberculosis drugs on the methemoglobin level among patients in treatment for pulmonary tuberculosis: A prospective study.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 273, doi. 10.1111/bcpt.13628
- By:
- Publication type:
- Article
3‐Quinuclidinyl benzilate (agent BZ) toxicokinetics in rats.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 246, doi. 10.1111/bcpt.13627
- By:
- Publication type:
- Article
Causes of discrepancies between medications listed in the national electronic prescribing system and patients' actual use of medications.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 221, doi. 10.1111/bcpt.13626
- By:
- Publication type:
- Article
Effectiveness and safety of oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate recurrence risk.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 210, doi. 10.1111/bcpt.13625
- By:
- Publication type:
- Article
Renin–angiotensin system in intestinal inflammation—Angiotensin inhibitors to treat inflammatory bowel diseases?
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 161, doi. 10.1111/bcpt.13624
- By:
- Publication type:
- Article
The association of polymorphisms in related circadian rhythm genes and clopidogrel resistance susceptibility.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 196, doi. 10.1111/bcpt.13622
- By:
- Publication type:
- Article
Combined treatment with FABP4 inhibitor ameliorates rosiglitazone‐induced liver steatosis in obese diabetic db/db mice.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 173, doi. 10.1111/bcpt.13621
- By:
- Publication type:
- Article
Development of a risk prediction nomogram for disposition of acute toxic exposure patients to intensive care unit.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 256, doi. 10.1111/bcpt.13619
- By:
- Publication type:
- Article
Risk of muscle toxicity events for daptomycin with and without statins: Analysis of the Japanese Adverse Event Report database.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 268, doi. 10.1111/bcpt.13618
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 129, n. 3, p. 159, doi. 10.1111/bcpt.13440
- Publication type:
- Article